The peptide boom illustrates how quickly emerging biomedical technologies can migrate from the laboratory into consumer culture often long before regulators or clinical evidence can keep pace.
In just the past month, stories have been published by PBS, Axios, AARP, Mens Health, The Hill, The New Yorker, MSN, NPR, The Washington Post, Los Angeles Times and Reuters, among others
Nitric Oxide: From Research to Therapeutics, Advances in Biochemistry in Health and Disease 22
Some research suggests Epithalon might modulate epigenetic regulators that control TERT expression, including DNA methylation patterns and histone modifications